Exhalix, LLC
Publicly observedAlbuquerque, United States
Seen in a public record (e.g. a government grant database); not otherwise verified.
Details and provenance
| Item | Value | Source | Status |
|---|---|---|---|
| Country | US | NIH RePORTER (opens in a new tab) 28 Sept 2026 | Publicly observed |
| City / locality | Albuquerque | NIH RePORTER (opens in a new tab) 28 Sept 2026 | Publicly observed |
| Name | Exhalix, LLC | NIH RePORTER (opens in a new tab) 28 Sept 2026 | Publicly observed |
| UEI (U.S. federal entity ID) | C1NVZ5M6E319 | NIH RePORTER (opens in a new tab) 28 Sept 2026 | Publicly observed |
Recorded events
- Grant16 Sept 2025Publicly observed
NIH SBIR/STTR award: Genie:S: On-Demand Sulfide Synthesis and Delivery Platform Technology for Ischemia Therapy
USD 350,000.00 · National Center for Advancing Translational Sciences · Source: NIH RePORTER (opens in a new tab)
- Grant15 Sept 2025Publicly observed
NIH SBIR/STTR award: A Hydrogen Sulfide Delivery Technology for Organ Preservation Therapy
USD 116,757.00 · National Institute of Diabetes and Digestive and Kidney Diseases · Source: NIH RePORTER (opens in a new tab)
- Grant15 Sept 2025Publicly observed
NIH SBIR/STTR award: A Hydrogen Sulfide Delivery Technology for Organ Preservation Therapy
USD 248,492.00 · National Institute of Diabetes and Digestive and Kidney Diseases · Source: NIH RePORTER (opens in a new tab)
Information only — not investment advice or an endorsement. Is this your company? Submit or update its details or request a correction.